Epigral Ltd
Epigral Ltd (EPIGRAL) last traded at ₹1,239, a market capitalisation of ₹5,345 crore, on a P/E of 19.8. Over the past 52 weeks the stock has ranged between ₹806 and ₹1,890. Epigral Ltd last reported results for the quarter ended Jun 2026, with sales of ₹705 crore and net profit of ₹100 crore. Figures are as of 25 Aug 2026 and are not real time.
Epigral Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Epigral Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹705 cr, up 16.1% from ₹607 cr a year earlier. Net profit was ₹100 cr, down 37.9% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 626 | 645 | 628 | 607 | 587 | 597 | 736 | 705 |
| Expenses | 448 | 463 | 454 | 443 | 455 | 494 | 569 | 526 |
| Operating profit | 178 | 183 | 173 | 163 | 132 | 103 | 168 | 179 |
| OPM % | 28% | 28% | 28% | 27% | 22% | 17% | 23% | 25% |
| Other income | 6 | 4 | 4 | 9 | 2 | 6 | -1 | 5 |
| Interest | 27 | -0 | 12 | 23 | 22 | 11 | 16 | 7 |
| Depreciation | 32 | 33 | 34 | 42 | 42 | 43 | 42 | 43 |
| Profit before tax | 125 | 154 | 131 | 107 | 70 | 55 | 110 | 134 |
| Tax % | 35% | 33% | 34% | -50% | 26% | 28% | 26% | 25% |
| Net profit | 81 | 104 | 87 | 161 | 51 | 39 | 81 | 100 |
| EPS (₹) | 19.57 | 24.02 | 20.14 | 37.25 | 11.87 | 9.07 | 18.76 | 23.12 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Epigral Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 829 | 1,551 | 2,188 | 1,929 | 2,550 | 2,527 | 2,626 |
| Operating profit | 261 | 509 | 689 | 481 | 711 | 566 | 582 |
| OPM % | 32% | 33% | 31% | 25% | 28% | 22% | 22% |
| Net profit | 101 | 253 | 353 | 196 | 358 | 332 | 271 |
| EPS (₹) | 24.48 | 60.84 | 85.03 | 47.14 | 82.91 | 76.95 | 62.82 |
TTM is the trailing twelve months to the most recent quarter.
Epigral Ltd growth and returns
- 10 Years
- %
- 5 Years
- 25%
- 3 Years
- 5%
- TTM
- 5%
- 10 Years
- %
- 5 Years
- 27%
- 3 Years
- -2%
- TTM
- -37%
- 10 Years
- %
- 5 Years
- 18%
- 3 Years
- 11%
- 1 Year
- -34%
- 10 Years
- %
- 5 Years
- 24%
- 3 Years
- 18%
- Last Year
- 16%
Epigral Ltd shareholding pattern
Promoters held 68.83% at Jun 2026, broadly unchanged since Jun 2025. FIIs 1.03% and DIIs 5.56%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 71.58% | 68.94% | 68.95% | 68.83% | 68.83% | 68.83% | 68.83% | 68.83% |
| FIIs | 2.10% | 3.01% | 3.01% | 3.06% | 2.71% | 2.36% | 1.54% | 1.03% |
| DIIs | 1.17% | 4.31% | 4.66% | 4.78% | 4.93% | 5.13% | 4.90% | 5.56% |
| Government | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Public | 25.12% | 23.71% | 23.34% | 23.30% | 23.52% | 23.67% | 24.71% | 24.56% |
| No. of shareholders | 83,176 | 81,697 | 80,878 | 79,951 | 78,605 | 77,562 | 77,583 | 76,305 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Epigral Ltd corporate filings
- Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday, 20.08.2026Company Updatelow impact
Cruxal's analysis: Epigral Limited has formally notified the exchange regarding a scheduled one-on-one…
Read the full analysis - Epigral Limited hereby informs that the officials of the Company are participating in EMKAY Confluence 2026 on 12th August, 2026Company Updatelow impact
Cruxal's analysis: Epigral Limited has announced that company officials will participate in the EMKAY…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Epigral Ltd
Cruxal reads every Epigral Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.